Pediatric Priority Review Voucher Designations Near 30; How Many Can Beat Sunset Date?
This article was originally published in RPM Report
Executive Summary
FDA has designated 29 products under the rare pediatric disease incentive program – all with the potential to win a voucher for a priority review of another product. That means two dozen products are racing the clock ahead of the September 30 sunset date for the program.
You may also be interested in...
Another Chance For VALID? Negative Reaction To FDA’s LDT Proposal May Reopen Legislative Talks
All of the witnesses testifying to a House E&C Committee hearing said they preferred the flexibility and targeted enforcement of the VALID Act to FDA’s proposed rule. Will Congress finally be spurred to act?
US FDA Advisory Panels May Look Different Across Centers, Despite Efforts To Standardize Process
As FDA is readying to go back to in-person advisory committee meetings this fall, the centers have different ideas about how to use their expert panels.
US FDA Oncology Diagnostics Pilot Is ‘Interim Step’ To Fill VALID Void, But ‘Stuck In Neutral’
Without sponsors willing to work with them and in the absence of legislation giving FDA authority over lab-developed tests, the agency has launched internal programs to both gain more oversight – and spur innovation.